BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND EXT2, Q93063, ENSG00000151348, 2132, SOTV AND Treatment
11 results:

  • 1. Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study.
    Chen YY; Guo WJ; Shi YF; Su F; Yu FH; Chen RA; Wang C; Liu JX; Luo J; Tan HY
    BMC Gastroenterol; 2023 Dec; 23(1):440. PubMed ID: 38097952
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The role of primary retroperitoneal lymph node dissection in the treatment of stage II seminoma.
    Sigg S; Fankhauser CD
    Curr Opin Urol; 2023 Jul; 33(4):245-251. PubMed ID: 37144886
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Outcomes Following Hypofractionated Stereotactic Radiotherapy to the Cavity After Surgery for Melanoma Brain Metastases.
    Gallo J; Garimall S; Shanker M; Castelli J; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
    Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):179-186. PubMed ID: 34642065
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The role of deep learning-based survival model in improving survival prediction of patients with glioblastoma.
    Moradmand H; Aghamiri SMR; Ghaderi R; Emami H
    Cancer Med; 2021 Oct; 10(20):7048-7059. PubMed ID: 34453413
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured cells.
    Sixto-López Y; Marhuenda E; García-Vazquez JB; Fragoso-Vazquez MJ; Rosales-Hernández MC; Zacarías-Lara O; Méndez-Luna D; Gómez-Vidal JA; Cornu D; Norbert B; Correa-Basurto J
    Cell Mol Neurobiol; 2022 Aug; 42(6):1909-1920. PubMed ID: 33740172
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
    Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
    Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pretreatment ADC Values Predict Response to Radiosurgery in Vestibular Schwannomas.
    Camargo A; Schneider T; Liu L; Pakpoor J; Kleinberg L; Yousem DM
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1200-1205. PubMed ID: 28408629
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long-term MRI surveillance after microsurgery for vestibular schwannoma.
    Miller ME; Lin H; Mastrodimos B; Cueva RA
    Laryngoscope; 2017 Sep; 127(9):2132-2138. PubMed ID: 28294345
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical outcomes following resection of giant spinal schwannomas: a case series of 32 patients.
    J Neurosurg Spine; 2017 Apr; 26(4):494-500. PubMed ID: 28084933
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
    Sobrin L; Schiffman JC; Markoe AM; Murray TG
    Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma.
    Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):797-802. PubMed ID: 15936562
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.